As we wind down for the holidays, the Venture Partners team wants to celebrate the accomplishments of our resilient community of world-class innovators, business partners and dedicated mentors. We’re excited to share our highlights of this year.
From February 16-18, 2021, Venture Partners will host the biggest Destination Startup® yet, showcasing 26 startups from 10 different universities across six states in the Rocky Mountain region—not just Colorado—and drawing investors from around the world. Registration is now open!
CBSA celebrated companies and organizations driving new health innovations to save and change lives around the world during their 2020 virtual Annual Awards Celebration.
This year's 12 LVC winners included LumenAstra, Endoculus, Gene-Lock, Think Bioscience, HeapSi, Vitro3D, Modern Shennong, OTORO Energy, TYNT, Blue Cubed, Minus Materials and Resonant Inclusions.
Mechanical Engineering Professor Franck Vernerey, Assistant Mechanical Engineering Professor Carson Bruns and ATLAS Institute received $477,000 from the National Science Foundation to begin this three-year project in January 2021. Their research may one day enable soft machines to fully integrate with our bodies to deliver drugs, target tumors, or repair aging or dysfunctional tissue.
Two CU Boulder spinouts and one technology were among 37 Colorado startups approved for funding as part of the Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program. The awards went to Darwin Biosciences, Think Biosciences and Assistant Mechanical Engineering Professor Carson Bruns.
Led by professors Jianliang Xiao and Wei Zhang, researchers are developing a wearable electronic device that’s “really wearable”—a stretchy and fully-recyclable circuit board that’s inspired by, and sticks onto, human skin.
The company was co-founded by CTO Dana Anderson, who is also a fellow of JILA and professor in the department of physics and electrical & computer engineering.
MyoKardia was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and developmental Biology at CU Boulder's BioFrontiers Institute, in 2012. Leinwand and her research lab continue to collaborate with the company, currently on finding new treatments for rare genetic diseases.
The Insider is Venture Partners at CU Boulder's monthly newsletter featuring the latest headlines, news, events, and emerging innovations coming out of the university. We have several editions for our audiences:
